Ann Rheum Dis

1. VAN DER WOUDE D, Toes REM
   Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?
   Ann Rheum Dis. 2024 Feb 20:ard-2023-224103. doi: 10.1136/ard-2023-224103.
   

   >> Share

   
   
2. TANG Z, Shi H, Liu HL, Cheng X, et al
   Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'.
   Ann Rheum Dis. 2024;83:e4.
   

   >> Share

   
   
3. BARBHAIYA M, Zuily S, Hendry AM, Manneville F, et al
   Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang et al.
   Ann Rheum Dis. 2024;83:e5.
   

   >> Share

   
   
4. DAMOISEAUX J, van Beers J
   Correspondence on "ACR/EULAR antiphospholipid syndrome classification criteria".
   Ann Rheum Dis. 2024;83:e6.
   

   >> Share

   
   
5. ERKAN D, Barbhaiya M, Zuily S, Bertolaccini ML, et al
   Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur et al.
   Ann Rheum Dis. 2024;83:e3.
   

   >> Share

   
   
6. BARBHAIYA M, Zuily S, Bertolaccini ML, Willis R, et al
   Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers.
   Ann Rheum Dis. 2024;83:e7.
   

   >> Share

   
   
7. MIRO-MUR FA, Alijotas-Reig J, Anunciacion-Llunell A, Marques-Soares J, et al
   Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'.
   Ann Rheum Dis. 2024;83:e2.
   

   >> Share

   
   
8. PEZOT M, Nocturne G, Belkhir R, Henry J, et al
   Obinutuzumab in patients with Sjogren's disease immunised against rituximab.
   Ann Rheum Dis. 2024;83:407-408.
   

   >> Share

   
   
9. DORNER T, Kaul M, Szanto A, Tseng JC, et al
   Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjogren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
   Ann Rheum Dis. 2024;83:360-371.
   

   >> Share

   
   

   
   Arthritis Res Ther

10. LI G, Fang Y, Xu N, Ding Y, et al
    Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes.
    Arthritis Res Ther. 2024;26:56.
    

    >> Share

    
    

    
    Clin Exp Immunol

11. IWAI T, Ohyama A, Osada A, Nishiyama T, et al
    Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.
    Clin Exp Immunol. 2024;215:302-312.
    

    >> Share

    
    

    
    Clin Exp Rheumatol

12. KHULLAR A, Dhir V, Saikia B, Yadav AK, et al
    Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFalpha and IFNgamma.
    Clin Exp Rheumatol. 2024 Feb 12. doi: 10.55563.
    

    >> Share

    
    
13. CEN X, Chen Y, Liu H, Luo Y, et al
    Methotrexate inhibits LPS-induced glycolysis in fibroblast-like synoviocytes isolated from patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2024 Feb 6. doi: 10.55563.
    

    >> Share

    
    
14. FEDERICO JA, Syvaranta SA, Tuohinen SS, Holmstrom MM, et al
    Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies.
    Clin Exp Rheumatol. 2024 Feb 6. doi: 10.55563.
    

    >> Share

    
    
15. ALP G, Cinakli H, Kurut Aysin I, Solmaz D, et al
    Challenges and insights in managing difficult-to-treat rheumatoid arthritis: real-world clinical perspectives.
    Clin Exp Rheumatol. 2024 Jan 31. doi: 10.55563.
    

    >> Share

    
    
16. GUO N, Li X, Movahedi M, Cesta A, et al
    Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry.
    Clin Exp Rheumatol. 2024 Jan 31. doi: 10.55563.
    

    >> Share

    
    

    
    Clin Orthop Relat Res

17. WALTER N, Szymski D, Kurtz SM, Alt V, et al
    What Are the Mortality, Infection, and Nonunion Rates After Periprosthetic Femoral Fractures in the United States?
    Clin Orthop Relat Res. 2023 Sep 5. doi: 10.1097/CORR.0000000000002825.
    

    >> Share

    
    

    
    Clin Rheumatol

18. PHAM C, Niu F, Hui RL, Le KN, et al
    Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto.
    Clin Rheumatol. 2024;43:1269-1270.
    

    >> Share

    
    
19. ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
    Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study.
    Clin Rheumatol. 2024;43:1253-1259.
    

    >> Share

    
    
20. BAO X
    Validation of new immune and inflammation-related diagnostic biomarkers for RA.
    Clin Rheumatol. 2024;43:949-958.
    

    >> Share

    
    
21. BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
    Sjogren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
    Clin Rheumatol. 2024;43:1093-1101.
    

    >> Share

    
    
22. SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
    Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Clin Rheumatol. 2024;43:1245-1251.
    

    >> Share

    
    
23. WANG B, Liu J, Zhao L
    Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study.
    Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
    

    >> Share

    
    
24. CHEN D, Zhang J
    Commentary on the factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
    

    >> Share

    
    

    
    Lancet

25. VAN DER HELM-VAN MIL AHM
    Abatacept in individuals with autoantibody-positive arthralgia at risk for rheumatoid arthritis.
    Lancet. 2024 Feb 14:S0140-6736(24)00055-2. doi: 10.1016/S0140-6736(24)00055.
    

    >> Share

    
    
26. RECH J, Tascilar K, Hagen M, Kleyer A, et al
    Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
    Lancet. 2024 Feb 13:S0140-6736(23)02650-8. doi: 10.1016/S0140-6736(23)02650.
    

    >> Share

    
    
27. COPE AP, Jasenecova M, Vasconcelos JC, Filer A, et al
    Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
    Lancet. 2024 Feb 13:S0140-6736(23)02649-1. doi: 10.1016/S0140-6736(23)02649.
    

    >> Share

    
    

    
    PLoS One

28. BERGMANS B, Jessurun N, van Lint J, Murk JL, et al
    Burden of non-serious infections during biological use for rheumatoid arthritis.
    PLoS One. 2024;19:e0296821.
    

    >> Share

    
    
29. DE ARAUJO BMM, de Miranda BM, Kowaltschuk TC, Goncalves FM, et al
    Impact of chronic diseases on the periapical health of endodontically treated teeth: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297020.
    

    >> Share

    
    

    
    Rheumatol Int

30. SHARMA P, Brown S, Sokoya EM
    Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve patient conversations around food choices?
    Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
    

    >> Share

    
    

    
    Z Rheumatol

31. SANDIKCI SC, Gultuna S, Ozisler C, Aydin FN, et al
    The role of orexin in fatigue and sleep quality in patients with primary Sjogren's syndrome.
    Z Rheumatol. 2024;83.
    

    >> Share

    
    
32. FIEHN C, Leipe J, Weseloh C, Bergner R, et al
    Assessment of interactions and dosage recommendations of synthetic DMARDs-Evidence-based and consensus-based recommendations based on a systematic literature search.
    Z Rheumatol. 2024;83.
    

    >> Share

    
    
33. SEIFERT O, Baerwald C
    Stimulation of the vagus nerve as a therapeutic principle.
    Z Rheumatol. 2024;83.
    

    >> Share

    
    
34. ALBRECHT K, Binder S, Minden K, Poddubnyy D, et al
    Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.
    Z Rheumatol. 2024;83.
    

    >> Share

    
    
35. ISIK AC, Kavas M, Tezcan ME
    Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients.
    Z Rheumatol. 2024;83.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share